CIBC World Market
FENC icon

CIBC World Market’s Fennec Pharmaceuticals FENC Stock Holding History

CIBC World Market’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-26,530
Closed -$133K – 1381
2024
Q3 		$133K Sell
26,530
-30,355
-53% -$176K ﹤0.01% 1251
2024
Q2 		$348K Sell
56,885
-13,180
-19% -$109K ﹤0.01% 1064
2024
Q1 		$779K Sell
70,065
-1,900
-3% -$19.1K ﹤0.01% 869
2023
Q4 		$807K Sell
71,965
-7,219
-9% -$59.8K ﹤0.01% 824
2023
Q3 		$595K Sell
79,184
-1,384
-2% -$11.3K ﹤0.01% 855
2023
Q2 		$711K Sell
80,568
-34,363
-30% -$286K ﹤0.01% 846
2023
Q1 		$956K Buy
114,931
+15,568
+16% +$144K ﹤0.01% 759
2022
Q4 		$954K Buy
+99,363
New +$879K ﹤0.01% 775

Other funds holding FENC

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SGL
Sonic GP LLC Honolulu, Hawaii $45.4M AUM 5.08% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIBC World Market's FENC Position: Q4 2024 in Review

CIBC World Market sold out of Fennec Pharmaceuticals (FENC) in Q4 2024, closing a stake of 26,530 shares — an estimated $133K sold.

CIBC World Market first reported a position in FENC in Q4 2022 and held it in 8 quarters. The position peaked at $956K in Q1 2023. 64 funds tracked by Wall St. Rank hold FENC as of Q4 2024.

  • CIBC World Market reported no remaining Fennec Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • CIBC World Market sold 26,530 Fennec Pharmaceuticals shares in Q4 2024, an estimated $133K.
  • CIBC World Market first reported a position in Fennec Pharmaceuticals in Q4 2022 and held it in 8 quarters.
  • CIBC World Market's Fennec Pharmaceuticals position peaked at $956K in Q1 2023.
  • 64 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q4 2024.

Based on CIBC World Market's 13F filing for Q4 2024, filed 23 Jan 2025.